Navigation Links
Vion Pharmaceuticals to Present at 20th Annual Bear Stearns Healthcare Conference
Date:9/10/2007

is news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, delayed or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies or clinical trials are not predictive of safety and efficacy results in later clinical trials, the need for additional research and testing, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Annual Report on Form 10-K for the year ended December 31, 2006 and the Company's Form 10-Q for the quarter ended June 30, 2007. In particular, there can be no assurance as to the results of any of the Company's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

COMPANY CONTACT: Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203)498-4210


'/>"/>
SOURCE Vion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , "The interface is the device," Nobel laureate ... properties to be found at the junctures where ... world of nanotechnology, the interfaces between layers of ... in such high-tech favorites as spintronics, high-temperature superconductors, ...
(Date:1/15/2014)... 2014 The Pittcon Organizing Committee is pleased ... Safety Tech , an e-Journal and producer of ... the second year for the co-location of Food Labs Conference ... provides that the registration fee to attend the two-day Food ...
(Date:1/15/2014)... Look inside the new Preferred Solutions® ... lab, from fluid handling to instruments to supplies. Many ... you order. , Preferred Solutions features a full ... L/S® model for precise flow control and dispensing to ...
(Date:1/15/2014)... England and SAN JOSE, California ... international biotechnology company developing antibody-drug conjugates for cancer, today announced ... Board of Directors. Dr Reynolds has over 20 years, development ... Medical Officer at Seattle Genetics. "I am delighted ...
Breaking Biology Technology:A deeper look at interfaces 2Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... YORK, June 15, 2011 NeoStem, Inc. ("NeoStem" or ... international biopharmaceutical company with product and service revenues, global ... business units – U.S. adult stem cells, China adult ... Kolbert, Vice President of Strategic Business Development, will present ...
... Vermillion, Inc. (NASDAQ: VRML ), a molecular ... Microcap Index when Russell Investments reconstitutes its family of U.S. ... additions posted on June 10, available at www.russell.com/indexes . ... in place for one year, means automatic inclusion in the ...
... June 15, 2011 , Pharma IQ is ... HTA Online event - ,Global HTA and CER Forum ... over the course of August. Health Technology Assessment ... assessed for pharmaceuticals in Australia, Canada,and the UK, while clinical ...
Cached Biology Technology:NeoStem to Present at Two Investor Events This Month 2NeoStem to Present at Two Investor Events This Month 3NeoStem to Present at Two Investor Events This Month 4Vermillion Announces Joining Russell Microcap® Index 2Vermillion Announces Joining Russell Microcap® Index 3Health Technology Assessment Goes Online 2Health Technology Assessment Goes Online 3
(Date:4/18/2014)... Ancient DNA adds a twist to the story of ... be published April 21 in the journal Proceedings of ... the bones of chickens that lived 200-2300 years ago in ... domestic chickens may have looked far different from the chickens ... the traits we associate with modern domestic chickens -- such ...
(Date:4/18/2014)... Asteroid and comet impacts can cause widespread ecological havoc, ... global scales. But new research from Brown University shows ... life at the time of an impact. , A ... found fragments of leaves and preserved organic compounds lodged ... Argentina. The material could provide a snapshot of environmental ...
(Date:4/17/2014)... the most densely forested and most densely populated quadrant ... human needs, values and practices. Disturbances associated with those ... and development, have set the stage for management issues ... reports. , The report Five anthropogenic factors that ... the Northern United States was published recently ...
Breaking Biology News(10 mins):Ancient DNA offers clues to how barnyard chickens came to be 2Impact glass stores biodata for millions of years 2Impact glass stores biodata for millions of years 3Five anthropogenic factors that will radically alter northern forests in 50 years 2Five anthropogenic factors that will radically alter northern forests in 50 years 3
... Titanium,s Core Technology in the Health Care Industry, ... Group, Ltd,(OTC Bulletin Board: TTNUF), a leading biometric ... a contract with Hong Kong,Polytechnic University Clinic for ... Titanium,s Biometric Facial Recognition technology. In,this newly designed ...
... discussion at the upcoming United Nations Climate Change ... deforestation and the critical role that remote sensing ... (Reduced Emissions from Deforestation and Degradation) mechanisms ... deforestation. Using synthetic aperture radar (SAR) data acquired ...
... of Texas at Austin has received $1.9 million to ... national decisions about placement of devices to detect nuclear ... provided the funds to improve the design of networks ... countries of the former Soviet Union that have insufficient ...
Cached Biology News:Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong 2Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong 3Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring 2Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring 3Improving detection of nuclear smuggling goal of computer model of mechanical engineer 2Improving detection of nuclear smuggling goal of computer model of mechanical engineer 3
... Continuing a tradition of progressive centrifuge ... CL3 series. The Centra-CL3 and Centra-CL3R (refrigerated) ... todays laboratory., Quality Control Over Sample ... and lock up to 99 protocols and ...
PP2B-Abeta (C-20)...
... isoprostanes produced from arachidonic acid during lipid peroxidation. ... rat. 8-iso PGE2 inhibits U-46619 or I-BOP-induced platelet ... µM, respectively. When infused into the renal artery ... mg/kg/min, 8-iso PGE2 decreases the GFR and renal ...
SMVT (N-14)...
Biology Products: